EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 288 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,458,000 | -2.4% | 59,866 | +3.3% | 0.09% | +7.0% |
| Q4 2021 | $2,518,000 | +26.9% | 57,929 | +46.2% | 0.09% | +26.5% |
| Q3 2021 | $1,984,000 | -21.5% | 39,633 | -1.2% | 0.07% | -16.0% |
| Q2 2021 | $2,527,000 | -14.4% | 40,118 | +26.3% | 0.08% | -21.4% |
| Q1 2021 | $2,952,000 | +45.6% | 31,775 | +40.5% | 0.10% | +30.4% |
| Q4 2020 | $2,027,000 | +7.2% | 22,618 | +23.7% | 0.08% | -8.1% |
| Q3 2020 | $1,890,000 | -21.6% | 18,287 | -40.0% | 0.09% | -22.5% |
| Q2 2020 | $2,412,000 | +27.8% | 30,495 | -6.6% | 0.11% | +16.8% |
| Q1 2020 | $1,888,000 | -16.1% | 32,633 | -21.8% | 0.10% | +31.9% |
| Q4 2019 | $2,251,000 | -1.8% | 41,724 | -4.8% | 0.07% | -2.7% |
| Q3 2019 | $2,292,000 | -8.9% | 43,847 | -15.8% | 0.07% | +13.8% |
| Q2 2019 | $2,515,000 | – | 52,068 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
| Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
| AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
| RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
| EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
| SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
| Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
| DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |